Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials

Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller, Richard Gray, Jacqueline K. Benedetti, Marc Buyse, Roberto Labianca, Jean Francois Seitz, Christopher J. O'Callaghan, Guido Francini, Axel Grothey, Michael O'Connell, Paul J. Catalano, Charles D. Blanke, David Kerr, Erin Green, Norman Wolmark, Thierry Andre, Richard M. Goldberg, Aimery De Gramont

Research output: Contribution to journal › Article › peer-review

608 Scopus citations

Fingerprint

Dive into the research topics of 'Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials'. Together they form a unique fingerprint.

Medicine & Life Sciences